Quality of Life Assessment in Patients With Epilepsy Using QOLIE-31

This observational study aims to assess quality of life in individuals with epilepsy using the Quality of Life in Epilepsy Inventory (QOLIE-31). A total of 90 adult patients with a clinical diagnosis of epilepsy will be evaluated through standardized questionnaires administered during routine clinical visits. The study seeks to characterize patient-reported quality of life across multiple domains and to provide insight into factors affecting daily functioning and well-being in people living with epilepsy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Saglik Bilimleri University Izmir Faculty of Medicine Department of Neurology

Izmir, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age ≥18 years

Clinical diagnosis of epilepsy confirmed by a neurologist

Ability to complete QOLIE-31 questionnaire

Informed consent provided

Exclusion criteria

Severe cognitive impairment

Acute medical or psychiatric condition interfering with participation

Inability to understand questionnaire

Treatment and study plan

Primary outcomes

Quality of life measured by QOLIE-31 total score

Time frame: At study enrollment

The Quality of Life in Epilepsy Inventory-31 is a validated epilepsy-specific quality of life scale consisting of 31 items. The total score ranges from 0 to 100. Higher scores indicate better health-related quality of life.

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Registry information

Official study title

Assessment of Health-Related Quality of Life in Adults With Epilepsy Using the Quality of Life in Epilepsy Inventory (QOLIE-31): A Cross-Sectional Observational Study

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Mar 4, 2026
Registry last updated: Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed